Intercept Pharmaceuticals Inc ICPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/24/21 EDT
16.06UNCH (UNCH)
Volume
11,989
Close
16.06quote price arrow down-0.28 (-1.71%)
Volume
465,637
52 week range
11.60 - 43.16
Loading...
  • Open16.13
  • Day High16.51
  • Day Low15.89
  • Prev Close16.34
  • 52 Week High43.16
  • 52 Week High Date10/06/20
  • 52 Week Low11.60
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap533.19M
  • Shares Out33.20M
  • 10 Day Average Volume1.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-34.98

KEY STATS

  • Open16.13
  • Day High16.51
  • Day Low15.89
  • Prev Close16.34
  • 52 Week High43.16
  • 52 Week High Date10/06/20
  • 52 Week Low11.60
  • 52 Week Low Date08/20/21
  • Market Cap533.19M
  • Shares Out33.20M
  • 10 Day Average Volume1.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-34.98

RATIOS/PROFITABILITY

  • EPS (TTM)-5.15
  • P/E (TTM)-3.12
  • Fwd P/E (NTM)-3.08
  • EBITDA (MRQ)-108.56M
  • ROE (MRQ)-143,254.90%
  • Revenue (MRQ)341.03M
  • Gross Margin (MRQ)98.82%
  • Net Margin (MRQ)-49.89%
  • Debt To Equity (MRQ)-283.38%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intercept Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a...
Paolo Fundaro
Non-Executive Chairman
Jerome Durso
President
Andrew Saik
Chief Financial Officer
Rocco Venezia
Chief Accounting Officer
Linda Richardson
Executive Vice President
Address
10 Hudson Yards Fl 37
New York, NY
10001-2160
United States

Top Peers

SYMBOLLASTCHG%CHG
MDXG
MiMedx Group Inc
6.25-0.01-0.16%
PBYI
Puma Biotechnology Inc
6.82-0.02-0.29%
MOR
MorphoSys AG
12.18-0.30-2.40%
AKBA
Akebia Therapeutics Inc
2.86-0.05-1.72%
CHRS
Coherus BioSciences Inc
17.73+0.21+1.20%